0001839882-23-006928.txt : 20230316
0001839882-23-006928.hdr.sgml : 20230316
20230316194334
ACCESSION NUMBER: 0001839882-23-006928
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230315
FILED AS OF DATE: 20230316
DATE AS OF CHANGE: 20230316
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stillwell Richard Newcomb
CENTRAL INDEX KEY: 0001966861
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36019
FILM NUMBER: 23740345
MAIL ADDRESS:
STREET 1: C/O TONIX PHARMACEUTICALS HOLDING CORP.
STREET 2: 26 MAIN STREET, SUITE 101
CITY: CHATHAM
STATE: NJ
ZIP: 07928
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tonix Pharmaceuticals Holding Corp.
CENTRAL INDEX KEY: 0001430306
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261434750
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 26 MAIN STREET, SUITE 101
CITY: CHATHAM
STATE: NJ
ZIP: 07928
BUSINESS PHONE: 212-980-9155
MAIL ADDRESS:
STREET 1: 26 MAIN STREET, SUITE 101
CITY: CHATHAM
STATE: NJ
ZIP: 07928
FORMER COMPANY:
FORMER CONFORMED NAME: TAMANDARE EXPLORATIONS INC.
DATE OF NAME CHANGE: 20080320
4
1
stillwell-form4_031523.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
X0306
4
2023-03-15
0
0001430306
Tonix Pharmaceuticals Holding Corp.
TNXP
0001966861
Stillwell Richard Newcomb
C/O TONIX PHARMACEUTICALS HOLDING CORP
26 MAIN ST., SUITE 101
CHATHAM
NJ
07928
1
0
0
0
Stock Option
0.562
2023-03-15
4
A
0
83000
0.00
A
2033-03-15
Common Stock
83000
83000
D
The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.
This option vests on the Issuer's 2023 Annual Meeting of Stockholders.
/s/ Jessica Morris as attorney-in-fact
2023-03-16